← FDA DRUG APPROVALS

FDA ANDA · ANDA074848

PROPOFOL

Sponsor: HIKMA

APPLICATION
ANDA074848
TYPE
ANDA
ORIGINAL APPROVAL
2005-04-19
LATEST ACTION
2023-08-30
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

PROPOFOLPrescription
PROPOFOL 10MG/ML · INJECTABLE · INJECTION

Approval history

2023-08-30Labeling · Supplement 15 · standardAP
2020-07-16Labeling · Supplement 6 · standardAP
2020-07-16Labeling · Supplement 9 · standardAP
2020-07-16Labeling · Supplement 7 · standardAP
2008-01-02Labeling · Supplement 4AP
2005-04-19OriginalOther Important Information from FDAAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →